X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-24 | RZLT | Hogenhuis Wladimir | Dir | P - Purchase | $4.70 | +4,259 | 41,767 | +11% | +$20,017 | ||||||
2024-06-25 | RZLT | Hogenhuis Wladimir | Dir | P - Purchase | $4.15 | +4,815 | 37,508 | +15% | +$19,982 | ||||||
2024-06-14 | RZLT | Roberts Brian Kenneth | Chief Medical Officer | P - Purchase | $3.91 | +7,600 | 68,728 | +12% | +$29,743 | ||||||
2024-06-14 | RZLT | Evans Daron | CFO | P - Purchase | $4.04 | +40,000 | 203,351 | +24% | +$161,568 | ||||||
2024-05-29 | RZLT | Evans Daron | CFO | P - Purchase | $3.50 | +451 | 163,351 | 0% | +$1,579 | ||||||
2024-05-23 | RZLT | Roberts Brian Kenneth | Chief Medical Officer | P - Purchase | $2.69 | +7,500 | 61,128 | +14% | +$20,138 | ||||||
| M | 2024-05-23 | RZLT | Evans Daron | CFO | P - Purchase | $3.22 | +3,000 | 162,900 | +2% | +$9,668 | |||||
2024-03-28 | RZLT | Roberts Brian Kenneth | Chief Medical Officer | P - Purchase | $2.55 | +500 | 53,628 | +1% | +$1,275 | ||||||
| M | 2021-10-15 | RZLT | Handok, Inc. | Dir, 10% | P - Purchase | $4.33 | +3,927,126 | 5,942,617 | +195% | +$17,000,003 | |||||
2024-03-15 | RZLT | Evans Daron | CFO | P - Purchase | $1.69 | +20,000 | 159,900 | +14% | +$33,830 | ||||||
2024-03-14 | RZLT | Roberts Brian Kenneth | Chief Medical Officer | P - Purchase | $1.88 | +10,000 | 53,128 | +23% | +$18,800 | ||||||
| A | 2024-03-07 | RZLT | Roberts Brian Kenneth | Chief Medical Officer | P - Purchase | $1.85 | +500 | 43,128 | +1% | +$925 | |||||
| M | 2022-07-22 | RZLT | Kim Young-Jin | Dir | P - Purchase | $3.20 | +115,450 | 6,058,067 | +2% | +$369,858 | |||||
2024-03-07 | RZLT | Roberts Brian Kenneth | Chief Medical Officer | P - Purchase | $1.85 | +500 | 43,052 | +1% | +$925 | ||||||
2024-03-08 | RZLT | Evans Daron | CFO | P - Purchase | $1.93 | +50,000 | 139,900 | +56% | +$96,345 | ||||||
2024-02-26 | RZLT | Elam Nevan C | CEO | P - Purchase | $1.68 | +5,000 | 7,817 | +177% | +$8,400 | ||||||
| M | 2024-02-23 | RZLT | Roberts Brian Kenneth | Chief Medical Officer | P - Purchase | $1.69 | +8,000 | 42,552 | +23% | +$13,540 | |||||
2024-02-16 | RZLT | Roberts Brian Kenneth | Chief Medical Officer | P - Purchase | $1.31 | +7,000 | 34,552 | +25% | +$9,142 | ||||||
2024-02-16 | RZLT | Evans Daron | CFO | P - Purchase | $1.31 | +50,900 | 89,900 | +131% | +$66,741 | ||||||
2023-07-03 | RZLT | Roberts Brian Kenneth | Chief Medical Officer | P - Purchase | $1.90 | +5,000 | 27,552 | +22% | +$9,500 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |